/PRNewswire/ -- Amgen (NASDAQ:AMGN) and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) today announced new results from the ongoing ROCKET Phase 3 clinical...

YouTube video by Rare Disease Day

In an ongoing phase 1 trial, the combination of two new immunotherapies targeting CTLA-4 and PD-1 was overall well tolerated and elicited encouraging clinical responses in patients with relapsed/refra...

Rare diseases often fly under the radar, affecting small patient populations and garnering limited public attention. Yet for those living with these conditions, the challenges are immense—delayed diag...

As we step into 2025, social listening is poised to evolve in groundbreaking ways, reshaping how brands engage with their audiences. The confluence of advanced technologies like artificial intelligenc...

Try Deep Research, a new research assistant in Gemini Advanced, and a chat optimized version of Gemini 2.0 Flash Experimental.

Pfizer Inc. (NYSE:PFE) and Alliance Foundation Trials, LLC (AFT) today announced results from the Phase 3 PATINA trial demonstrating that the addition

The migration from X (formerly Twitter) to Bluesky by healthcare professionals (HCPs) highlights an evolving need for reliable, professional, and user-centered digital platforms. Bluesky’s recent grow...

Many compare it to the early days of Twitter

How to Switch from Twitter to Bluesky: A Comprehensive Guide Social media has seen an evolution with platforms like Bluesky offering decentralized, user-centric experiences. If you’re looking to make ...

Authors, websites, and apps can use action intent links to implement "Share on Bluesky" buttons, or similar in-app actions. Logged-in users will be directed to the corresponding action view in the Blu...

Facts, data, and analytics about biomedical matters.